A novel aldo-keto reductase (AKR) was cloned and sequenced from roots of Aloe arborescens by a combination of RT-PCR using degenerate primers based on the conserved sequences of plant polyketide reductases (PKRs) and cDNA library screening by oligonucleotide hybridization. A. arborescens AKR share similarities with known plant AKRs (40-66% amino acid sequence identity), maintaining most of the active-site residues conserved in the AKR superfamily enzymes. Interestingly, despite the sequence similarity with PKRs, recombinant enzyme expressed in Escherichia coli did not exhibit any detectable PKR activities. Instead, A. arborescens AKR catalyzed NADPH-dependent reduction of various carbonyl compounds including benzaldehyde and DL-glyceraldehyde. Finally, a homology model on the basis of the crystal structure of Hordeum vulgare AKR predicted the active-site architecture of the enzyme.

Download full-text PDF

Source
http://dx.doi.org/10.1248/bpb.30.2262DOI Listing

Publication Analysis

Top Keywords

novel aldo-keto
8
aldo-keto reductase
8
aloe arborescens
8
arborescens akr
8
akr
5
cloning functional
4
functional analysis
4
analysis novel
4
reductase aloe
4
arborescens
4

Similar Publications

Metabolic rewiring is required for cancer cells to survive in harsh microenvironments and is considered to be a hallmark of cancer. Specific metabolic adaptations are required for a tumor to become invasive and metastatic. Cell division and metabolism are inherently interconnected, and several cell cycle modulators directly regulate metabolism.

View Article and Find Full Text PDF

Expression, characterization, and application of an aldo-keto reductase mined from Bacillus velezensis Vel-HNGD-F2 for deoxynivalenol biodegradation.

Food Chem Toxicol

November 2024

College of Food Science and Engineering, Henan Key Laboratory of Cereal and Oil Food Safety and Nutrition, Henan University of Technology, Zhengzhou, Henan, 450001, China.

Article Synopsis
  • Deoxynivalenol (DON) is a harmful contaminant in cereals that poses health risks to humans and animals, and existing detoxification methods are not effective in specifically targeting DON while maintaining nutrient levels.
  • Researchers identified a new enzyme, AKR11A2, from Bacillus velezensis that can effectively degrade DON, showing optimal activity at pH 9 and 40°C, and maintaining over 90% stability under high temperatures and alkaline conditions.
  • The enzyme successfully reduced DON levels in contaminated corn by 50.69% and produced a less toxic compound, 3-epi-DON, indicating its potential as a practical solution for improving food safety.
View Article and Find Full Text PDF

The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia.

Blood Cancer J

November 2024

Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, NSW, Australia.

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that expresses high levels of the enzyme aldo-keto reductase family 1 member C3 (AKR1C3). To exploit this finding, we developed a novel prodrug, ACHM-025, which is selectively activated by AKR1C3 to a nitrogen mustard DNA alkylating agent. We show that ACHM-025 has potent in vivo efficacy against T-ALL patient-derived xenografts (PDXs) and eradicated the disease in 7 PDXs.

View Article and Find Full Text PDF

In this study, a series of 13 new D-ring fused steroidal (2)-substituted-1,2,3-triazoles were synthesized, characterized and evaluated for their biological activities. The relative binding affinities of the synthesized compounds for the ligand-binding domains of estrogen receptors α and β, androgen receptor and glucocorticoid receptor demonstrated that androstane derivatives 3a and 3h and estratriene derivative 4e showed highly specific and strong binding affinity for estrogen receptor β, while 3b, 3e, 4a and 4b displayed high binding affinity for the glucocorticoid receptor. The synthesized compounds were tested for their ability to inhibit aldo-keto reductases 1C3 and 1C4 by monitoring NADPH consumption using fluorescence spectroscopy.

View Article and Find Full Text PDF
Article Synopsis
  • Atrophic nonunion is a persistent health issue with no effective treatment options, leading researchers to investigate new targets using high-throughput mRNA sequencing.
  • The study identified AKR1B10, an enzyme that is overexpressed in atrophic nonunion tissues, and explored its impact on bone stem cells and bone healing.
  • Results indicated that AKR1B10 inhibits important processes for bone formation and repair, which suggests that targeting this enzyme could be a new treatment strategy for improving bone fracture healing.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!